Search for Clinical Trial Results
Osteoporosis, Postmenopausal - 27 Studies Found
Status | Study |
Completed |
Study Name: Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan Condition: Osteoporosis, Postmenopausal Date: 2011-07-19 Interventions: Drug: E2 transdermal (Julina, BAY86-5435) Patients in daily life treatment receiving Julina for postmeno |
Completed |
Study Name: Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment Condition: Osteoporosis, Postmenopausal Date: 2010-06-03 Interventions: Other: OPSAT-Q A linguistically validated Korean version of OPSAT-Q |
Completed |
Study Name: 2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis Condition: Osteoporosis, Postmenopausal Date: 2005-09-12 Interventions:
|
Completed |
Study Name: Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D) Condition: Osteoporosis, Postmenopausal Date: 2006-01-03 Interventions:
|
Completed |
Study Name: Julina Post-marketing Surveillance for Climacteric Symptoms in Japan Condition: Osteoporosis, Postmenopausal Date: 2011-06-16 Interventions: Drug: E2 transdermal (Julina, BAY86-5435) Patients in daily life treatment receiving Julina for postmeno |
Completed |
Study Name: Study With AMG 785 to Treat Japanese Women With Postmenopausal Osteoporosis Condition: Postmenopausal Osteoporosis (PMO) Date: 2013-11-19 Interventions:
|
Completed |
Study Name: Risedronate Sodium in Post Menopausal Osteoporosis Condition: Osteoporosis, Postmenopausal Date: 2007-03-28 Interventions: Drug: risedronate sodium |
Completed |
Study Name: Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis Condition: Osteoporosis, Post-Menopausal Date: 2007-09-18 Interventions: Drug: Teriparatide Teriparatide 20 micrograms/daily subcutaneously |
Completed |
Study Name: Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Denosumab (Prolia®) in Routine Clinical Practice Condition: Osteoporosis, Postmenopausal Date: 2012-07-26 Interventions: Biological: Denosumab This is an non-interventional study, therefore denosumab is administered as part o |
Completed |
Study Name: Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in Pakistan Condition: Postmenopausal Osteoporosis Date: 2015-04-16 |